Edition:
United States

Genfit SA (GNFT.PA)

GNFT.PA on Paris Stock Exchange

15.38EUR
23 Aug 2019
Change (% chg)

€-0.07 (-0.45%)
Prev Close
€15.45
Open
€15.41
Day's High
€15.50
Day's Low
€15.23
Volume
163,488
Avg. Vol
300,217
52-wk High
€24.50
52-wk Low
€13.35

About

Genfit SA is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of diabetes and related disorders. The Company is focused on contributing to bringing medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect... (more)

Overall

Beta: 1.34
Market Cap(Mil.): €635.67
Shares Outstanding(Mil.): 38.83
Dividend: --
Yield (%): --

Financials

  GNFT.PA Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -2.55 -- --
ROI: -34.85 7.52 12.69
ROE: -129.94 7.94 17.13

BRIEF-Genfit Raises Circa $155.4 Million Gross In Nasdaq Offering

* ANNOUNCED ON THURSDAY EXERCISE IN FULL OF THE OPTION GRANTED TO THE UNDERWRITERS OF ITS GLOBAL OFFERING AND NASDAQ GLOBAL SELECT MARKET LISTING TO PURCHASE UP TO 997,500 ADDITIONAL ADSS

Mar 29 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates